Targeted Fab fragments dismantle the allergy trigger
Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such…
Reduced peanut OIT dose offers safer, accessible treatment for children
Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection to peanut, finds a new study led by The Hospital for…
Research Roundup (October 2025) – First10EM
There are, I think, some very interesting papers this time around. Physicians vs AI: ECG edition Shroyer S,…
First-generation antihistamines increase delirium risk in older hospitalized patients
An analysis in the Journal of the American Geriatrics Society reveals that older inpatients admitted to physicians who…
Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis
ARS Pharmaceuticals, Inc. Findings accepted for publication in the official journal of the American College of Allergy, Asthma…